Drug intelligence / Profile preview

CAVIFIX

Development stage: Unknown
Lead developer: Droplet Life Science
Modality: Small Molecules
Administration: Topical

Overview

CAVIFIX is a topical oral care toothpaste formulation developed by Droplet Life Science, an Indian pharmaceutical company. The product is specifically designed for oral and dental hygiene, focusing on the prevention of dental caries through the remineralization of tooth enamel. Its primary active ingredient is calcium sucrose phosphate, which serves as a source of calcium and phosphate ions to re-harden and strengthen enamel. Marketed as an anti-cavity technology, CAVIFIX is claimed to provide superior remineralization compared to casein phosphopeptide-amorphous calcium phosphate (CPP-ACP). The formulation also includes standard toothpaste components such as sorbitol, silica, and glycerin.

Brand names: CAVIFIX
Other names: CAVIFIX toothpaste

Beyond the preview

Go deeper on CAVIFIX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAVIFIX.

Explore the full profile